People · Operator
Named in public records as an officer, director or promoter · active 2012–2015 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vensun Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $39.9M | $663.1M | 2012 |
Jason G. Wild at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jason G. Wild on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Syed E. Abidi | 1 | 3 |
| Hemanshu Pandya | 1 | 3 |
| Dhananjay G. Wadekar | 1 | 2 |
| Kamlesh E. Haribhakti | 1 | 1 |
| Michael G. Altman | 1 | 1 |
| Jason E. Wild | 1 | 1 |
| Kamlesh G. Haribhakti | 1 | 1 |
| Edward G. Schutter | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.